Product Information
GONAL-F RFF REDI-JECT 450 UNIT PEN is a brand product labeled by EMD Serono, Inc., priced at $1846.9120 per ML under NDC 44087111601. Its NADAC has been published 68 times since Apr 17, 2024.
Strength
450 [iU]/.75mL
Manufacturer
EMD Serono, Inc.NDC
44087111601
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
10/23/2024
Active Ingredients
FOLLITROPINApproval Type
Biologic (BLA)
FDA Application
BLA021684On Market Since
10/16/2013
Pharmacological Classes
Price Statistics
The NADAC for GONAL-F RFF REDI-JECT 450 UNIT PEN has been published 68 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1846.9120 per ML |
|---|---|
| All-time high | $1850.3511 (Sep 11, 2024) |
| All-time low | $1846.9120 (Sep 18, 2024) |
| 52-week high | $1846.9120 |
| 52-week low | $1846.9120 |
| Median price | $1846.9120 |
| Average price | $1848.0247 |
| Largest weekly change | -0.2% (Sep 18, 2024) |
| Weeks tracked | 68 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the FOLLITROPIN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GONAL-F RFF REDI-JECT 450 UNIT PEN?
The current National Average Drug Acquisition Cost (NADAC) for GONAL-F RFF REDI-JECT 450 UNIT PEN, manufactured by EMD Serono, Inc., is $1846.9120 per ML (NDC 44087111601), effective Jul 30, 2025.
How has the price of GONAL-F RFF REDI-JECT 450 UNIT PEN changed over time?
Over the history we have for it, the NADAC for GONAL-F RFF REDI-JECT 450 UNIT PEN has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GONAL-F RFF REDI-JECT 450 UNIT PEN?
Since Apr 17, 2024, the NADAC for GONAL-F RFF REDI-JECT 450 UNIT PEN has ranged from a low of $1846.9120 (Sep 18, 2024) to a high of $1850.3511 (Sep 11, 2024), with a median of $1846.9120 per ML.
Are there cheaper alternatives to GONAL-F RFF REDI-JECT 450 UNIT PEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GONAL-F RFF REDI-JECT 450 UNIT PEN, so no direct lower-cost alternative is listed.
Who manufactures GONAL-F RFF REDI-JECT 450 UNIT PEN?
GONAL-F RFF REDI-JECT 450 UNIT PEN (NDC 44087111601) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification